commercialization News
Most Popular commercialization Story
CGI wins $25M up front for Genentech collaboration
Genentech has agreed to pay CGI Pharmaceuticals $25 million up front and up to $500 million in milestones for the rights to collaborate on the development and commercialization of therapeutics for an unidentified target for the treatment of multiple cancer and autoimmune indications. No other financial details were disclosed. Genentech gained exclusive rights outside of the U.S. and the European Union.
"CGI has …
Read more...Latest Headlines
- May 27, 2008
- May 23, 2008
- May 2, 2008
- April 21, 2008
- March 27, 2008
- March 17, 2008
- March 11, 2008
- March 10, 2008
- February 12, 2008
- January 29, 2008
- December 14, 2007
- December 7, 2007
- November 26, 2007
- November 5, 2007
- October 19, 2007
- October 9, 2007
- September 28, 2007
- September 14, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
